Rodman David Malcom bought MLYS
January 5, 2026 · Form 4 insider transaction
Rodman David Malcom bought 10,121 shares of Mineralys Therapeutics, Inc. at $15.44 per share, a transaction worth $156.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
10,121
Price
$15.44
Total value
$156.3K
InsiderRodman David Malcom
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJanuary 5, 2026
Filing dateJanuary 6, 2026
Shares owned after107,347
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted on October 6, 2025.